Exact Sciences
EXAS
#1154
Rank
NZ$33.29 B
Marketcap
NZ$175.46
Share price
-0.07%
Change (1 day)
64.84%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): NZ-$9.42

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is NZ-$9.24. In 2024 the company made an earnings per share (EPS) of NZ-$9.67.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$9.42-2.57%
2024NZ-$9.67
2022NZ-$6.152.31%
2021NZ-$6.01-38.54%
2020NZ-$9.77692.96%
2019NZ-$1.23-50.69%
2018NZ-$2.5044%
2017NZ-$1.74-39.39%
2016NZ-$2.86-2.94%
2015NZ-$2.9537.1%
2014NZ-$2.1579.71%
2013NZ-$1.20-21.59%
2012NZ-$1.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
NZ-$7.52-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.59-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
NZ$0.68-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ-$88.37 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.43-169.66%๐Ÿ‡ซ๐Ÿ‡ท France